Mammalian cells obtain nucleic acid precursors through the de novo synthesis of nucleotides and the salvage of exogenous nucleobases and nucleosides. The first step in the salvage pathway is transport across the plasma membrane. Several transport activities, including equilibrative and concentrative mechanisms, have been identified by their functional properties. We report here the functional cloning of a 2.6-kilobase pair human cDNA encoding the nitrobenzylmercaptopurine riboside (NBMPR)-insensitive, equilibrative nucleoside transporter ei by functional complementation of the transport deficiency in a subline of CEM human leukemia cells. Expression of this cDNA conferred an NBMPR-insensitive, sodium-independent nucleoside transport activity to the cells that exhibited substrate specificity and inhibitor sensitivity characteristic of the ei transporter. The cDNA contained a single open reading frame that encoded a 456-residue protein with 11 potential membrane-spanning regions and two consensus sites for N-glycosylation in the first predicted extracellular loop. The predicted protein was 50% identical to the recently cloned human NBMPR-sensitive, equilibrative nucleoside transporter ENT1 and thus was designated ENT2. Surprisingly, the carboxyl-terminal portion of the ENT2 protein was nearly identical to a smaller protein in the GenBank TM data base (human HNP36, 326 residues) that has been identified as a growth factor-induced delayed early response gene of unknown function. Comparison of the ENT2 and HNP36 nucleotide sequences suggested that HNP36 was translated from a second start codon within the ENT2 open reading frame. Transient expression studies with the full-length ENT2 and a 5-truncated construct that lacks the first start codon (predicted protein 99% identical to HNP36) demonstrated that only the full-length construct conferred uridine transport activity to the cells. These data suggest that the delayed early response gene HNP36 is a truncated form of ENT2 and that the fulllength open reading frame of ENT2 is required for production of a functional plasma membrane ei transporter.Nucleoside transporters play an important role in the salvage of exogenous physiological nucleosides such as thymidine and uridine and in the uptake of antitumor and antiviral nucleoside analogs. At least five distinct nucleoside transport activities have been identified that differ in their permeant selectivity, sensitivity to inhibitors, and distribution in normal tissues and tumors (reviewed in Refs. 1 and 2). Two of these are equilibrative mechanisms that mediate both the influx and efflux of nucleosides across the plasma membrane, whereas the other three are concentrative, sodium-dependent mechanisms that under physiological conditions mediate only the influx of nucleosides. The major equilibrative carrier in most cells, es (equilibrative, sensitive), is highly sensitive to the inhibitor nitrobenzylmercaptopurine riboside (NBMPR) 1 with IC 50 values of 0.1 to 1 nM. Many cells, however, have a second equilibrative transport...